TcLand Expression, a spin-out of the French research institute INSERM/ITERT that focuses on gene expression biomarkers in immunology, has appointed Alessandra Cervino as vice president of bioinformatics and biostatistics, and Patrick Larcier, as vice president of clinical and regulatory affairs.
Cervino will manage the statistical and bioinformatics teams. Previous to TcLand Expression, she was head of statistical sciences and assistant professor at Scripps Florida, where she conducted a genome-wide study of lupus and developed a workflow to combine genotypic and transcriptomic data to identify novel genes.
She was group leader in statistical genetics at Rosetta/Merck, where she worked to translate genetic research programs into new drug targets and pharmacogenetic programs. She holds a PhD in clinical medicine from the University of Oxford.
Larcier will run clinical and regulatory operations, and will be responsible for the global relationship with regulatory agencies. Before joining the firm, he was vice president of drug development at Neovacs, an antibody-therapy company, and associate director of international regulatory affairs at Biogen.